
Loading, please wait...

Loading, please wait...

Scientists have identified a potentially groundbreaking treatment for cisplatin-resistant lung cancer using compounds derived from a mangrove-associated fungus. The study focused on Aspergillus sp. H6a, which yielded eighteen distinct compounds. Researchers isolated four new naphtho-γ-pyrone dimers, named aurasperones I-L, alongside various monomeric precursors. This discovery significantly expands our understanding of chemical diversity within mangrove-derived species.
Notably, the research team evaluated the cytotoxicity of these compounds against A549 cancer cells. Consequently, Compound 10 emerged as the most potent candidate. It demonstrated an IC50 value of 11.27 µM, which is highly comparable to the standard chemotherapy drug cisplatin. Furthermore, the compound maintained its effectiveness against DDP-resistant A549 cells. While cisplatin's efficacy dropped significantly in resistant cells, Compound 10 retained a potent IC50 of 12.58 µM. Additionally, using Compound 10 in combination with cisplatin further enhanced the overall inhibitory effect.
Moreover, these findings highlight the potential for natural products to bypass established drug resistance mechanisms. Therefore, Compound 10 represents a promising lead for future oncological therapies. However, translating these in vitro results into clinical practice for patients requires further study. Specifically, spectroscopic data and ECD analysis confirmed the absolute configurations of these complex compounds.
Compound 10 is significant because it maintains high potency against cancer cells that have developed resistance to cisplatin. It also enhances the effects of cisplatin when used as a combination therapy.
Researchers isolated the compound from Aspergillus sp. H6a. This is an endophytic fungus that lives within mangrove-associated environments.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zheng X et al. Bioactive Pyranones Isolated From the Mangrove-Associated Endophytic Fungus Aspergillus sp. H6a. Chem Biodivers. 2026 Jun undefined. doi: 10.1002/cbdv.71376. PMID: 42218802.
Ancheeva E, Daletos G, Proksch P. Bioactive secondary metabolites from endophytic fungi. Curr Med Chem. 2020;27(11):1836-1854.
Zheng R, Li S, Zhang X, Zhao C. Biological activities of some new secondary metabolites isolated from endophytic fungi: A review study. Int J Mol Sci. 2021;22(2):959.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies bioactive pyranones from a mangrove fungus that show potent activity against cisplatin-resistant lung cancer cells....
3 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today